Melphalan
FDA Approved
Contents
Description
Melphalan is a chemotherapy drug used to treat multiple myeloma and ovarian cancer. It is an alkylating agent that works by damaging the DNA of cancer cells, preventing them from growing and dividing.
Indications & Therapeutic Use
Multiple Myeloma, Ovarian Cancer
Linked Diseases:
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Melphalan — GNH India
101 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Alkeran
EU
Demephan
EU
Mederan 50mg
50mgvialsIndia
Mederan
2mgtabletIndia
Melfalán Aspen
EU
Melfalan Eugia
EU
Melfalan Hikma
EU
Melfalán Hikma
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Melphalan
| Generic Name | Melphalan |
| Brands | 1 brand available |
| Active Ingredient | Melphalan |
| Drug Class | Multiple Myeloma |
| Manufacturer | GlaxoSmithKline |
| Dosage Forms | Tablets, Injection |
| Medical Code | L01AA03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes